nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—chronic obstructive pulmonary disease	0.603	1	CbGaD
Pyrazinamide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0688	0.257	CbGbCtD
Pyrazinamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.056	0.209	CbGbCtD
Pyrazinamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0378	0.141	CbGbCtD
Pyrazinamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0361	0.135	CbGbCtD
Pyrazinamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0321	0.12	CbGbCtD
Pyrazinamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0189	0.0705	CbGbCtD
Pyrazinamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0178	0.0666	CbGbCtD
Pyrazinamide—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.00294	0.0373	CcSEcCtD
Pyrazinamide—XDH—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.00287	0.0573	CbGpPWpGaD
Pyrazinamide—AOX1—Effects of Nitric Oxide—NOS2—chronic obstructive pulmonary disease	0.00286	0.0571	CbGpPWpGaD
Pyrazinamide—XDH—Effects of Nitric Oxide—NOS2—chronic obstructive pulmonary disease	0.00266	0.0531	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00255	0.0509	CbGpPWpGaD
Pyrazinamide—AOX1—Effects of Nitric Oxide—NOS3—chronic obstructive pulmonary disease	0.0023	0.0459	CbGpPWpGaD
Pyrazinamide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00223	0.0444	CbGpPWpGaD
Pyrazinamide—XDH—Effects of Nitric Oxide—NOS3—chronic obstructive pulmonary disease	0.00214	0.0427	CbGpPWpGaD
Pyrazinamide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.0269	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.002	0.0254	CcSEcCtD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00197	0.0393	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.00187	0.0373	CbGpPWpGaD
Pyrazinamide—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.023	CcSEcCtD
Pyrazinamide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00161	0.0321	CbGpPWpGaD
Pyrazinamide—Gout—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.0203	CcSEcCtD
Pyrazinamide—Gout—Formoterol—chronic obstructive pulmonary disease	0.0016	0.0203	CcSEcCtD
Pyrazinamide—XDH—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00129	0.0258	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00121	0.0242	CbGpPWpGaD
Pyrazinamide—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.0154	CcSEcCtD
Pyrazinamide—AOX1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0012	0.024	CbGpPWpGaD
Pyrazinamide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.0152	CcSEcCtD
Pyrazinamide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0147	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.0145	CcSEcCtD
Pyrazinamide—XDH—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.00114	0.0228	CbGpPWpGaD
Pyrazinamide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.0139	CcSEcCtD
Pyrazinamide—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.0138	CcSEcCtD
Pyrazinamide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0137	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000958	0.0121	CcSEcCtD
Pyrazinamide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.0117	CcSEcCtD
Pyrazinamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000914	0.0116	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000908	0.0115	CcSEcCtD
Pyrazinamide—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000881	0.0112	CcSEcCtD
Pyrazinamide—AOX1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000873	0.0174	CbGpPWpGaD
Pyrazinamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000867	0.011	CcSEcCtD
Pyrazinamide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000836	0.0106	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.000832	0.0105	CcSEcCtD
Pyrazinamide—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000829	0.0105	CcSEcCtD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000818	0.0163	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000815	0.0162	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000812	0.0162	CbGpPWpGaD
Pyrazinamide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000775	0.00982	CcSEcCtD
Pyrazinamide—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000736	0.00933	CcSEcCtD
Pyrazinamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000692	0.0138	CbGpPWpGaD
Pyrazinamide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00069	0.00874	CcSEcCtD
Pyrazinamide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00069	0.00874	CcSEcCtD
Pyrazinamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000669	0.00847	CcSEcCtD
Pyrazinamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000669	0.00847	CcSEcCtD
Pyrazinamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000663	0.0084	CcSEcCtD
Pyrazinamide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000663	0.0084	CcSEcCtD
Pyrazinamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00063	0.0126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000627	0.0125	CbGpPWpGaD
Pyrazinamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000625	0.00792	CcSEcCtD
Pyrazinamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00782	CcSEcCtD
Pyrazinamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00061	0.00773	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00769	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00769	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000603	0.00764	CcSEcCtD
Pyrazinamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00747	CcSEcCtD
Pyrazinamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00747	CcSEcCtD
Pyrazinamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00738	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00726	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00724	CcSEcCtD
Pyrazinamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00706	CcSEcCtD
Pyrazinamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00703	CcSEcCtD
Pyrazinamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00697	CcSEcCtD
Pyrazinamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00697	CcSEcCtD
Pyrazinamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00691	CcSEcCtD
Pyrazinamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00691	CcSEcCtD
Pyrazinamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00666	CcSEcCtD
Pyrazinamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00666	CcSEcCtD
Pyrazinamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00666	CcSEcCtD
Pyrazinamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00658	CcSEcCtD
Pyrazinamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00655	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00649	CcSEcCtD
Pyrazinamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00629	CcSEcCtD
Pyrazinamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00618	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00616	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00616	CcSEcCtD
Pyrazinamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000486	0.00969	CbGpPWpGaD
Pyrazinamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00609	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00604	CcSEcCtD
Pyrazinamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00595	CcSEcCtD
Pyrazinamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00595	CcSEcCtD
Pyrazinamide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000469	0.00936	CbGpPWpGaD
Pyrazinamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.00593	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00584	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00584	CcSEcCtD
Pyrazinamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00583	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00582	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00572	CcSEcCtD
Pyrazinamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00565	CcSEcCtD
Pyrazinamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00562	CcSEcCtD
Pyrazinamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.0056	CcSEcCtD
Pyrazinamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.0056	CcSEcCtD
Pyrazinamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00557	CcSEcCtD
Pyrazinamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00557	CcSEcCtD
Pyrazinamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00555	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00551	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000429	0.00855	CbGpPWpGaD
Pyrazinamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00537	CcSEcCtD
Pyrazinamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00537	CcSEcCtD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.00842	CbGpPWpGaD
Pyrazinamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00535	CcSEcCtD
Pyrazinamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00535	CcSEcCtD
Pyrazinamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00533	CcSEcCtD
Pyrazinamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00528	CcSEcCtD
Pyrazinamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00528	CcSEcCtD
Pyrazinamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00528	CcSEcCtD
Pyrazinamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00526	CcSEcCtD
Pyrazinamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00526	CcSEcCtD
Pyrazinamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00524	CcSEcCtD
Pyrazinamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00507	CcSEcCtD
Pyrazinamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00505	CcSEcCtD
Pyrazinamide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000397	0.00793	CbGpPWpGaD
Pyrazinamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00498	CcSEcCtD
Pyrazinamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00498	CcSEcCtD
Pyrazinamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00498	CcSEcCtD
Pyrazinamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00488	CcSEcCtD
Pyrazinamide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.00766	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000382	0.00761	CbGpPWpGaD
Pyrazinamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00479	CcSEcCtD
Pyrazinamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00479	CcSEcCtD
Pyrazinamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00471	CcSEcCtD
Pyrazinamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00469	CcSEcCtD
Pyrazinamide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000368	0.00734	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000362	0.00721	CbGpPWpGaD
Pyrazinamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00452	CcSEcCtD
Pyrazinamide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000353	0.00704	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.00677	CbGpPWpGaD
Pyrazinamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.0043	CcSEcCtD
Pyrazinamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000339	0.0043	CcSEcCtD
Pyrazinamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00426	CcSEcCtD
Pyrazinamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00426	CcSEcCtD
Pyrazinamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00426	CcSEcCtD
Pyrazinamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00426	CcSEcCtD
Pyrazinamide—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000333	0.00663	CbGpPWpGaD
Pyrazinamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00421	CcSEcCtD
Pyrazinamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00033	0.00418	CcSEcCtD
Pyrazinamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00417	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000329	0.00656	CbGpPWpGaD
Pyrazinamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.00416	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000328	0.00655	CbGpPWpGaD
Pyrazinamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00406	CcSEcCtD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00638	CbGpPWpGaD
Pyrazinamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00405	CcSEcCtD
Pyrazinamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00403	CcSEcCtD
Pyrazinamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00402	CcSEcCtD
Pyrazinamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00402	CcSEcCtD
Pyrazinamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00402	CcSEcCtD
Pyrazinamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00394	CcSEcCtD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00612	CbGpPWpGaD
Pyrazinamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00379	CcSEcCtD
Pyrazinamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00378	CcSEcCtD
Pyrazinamide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000295	0.00587	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00028	0.00558	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00557	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000267	0.00533	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000264	0.00526	CbGpPWpGaD
Pyrazinamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00512	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00493	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00492	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000245	0.00488	CbGpPWpGaD
Pyrazinamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00303	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00302	CcSEcCtD
Pyrazinamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00294	CcSEcCtD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000231	0.00461	CbGpPWpGaD
Pyrazinamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00291	CcSEcCtD
Pyrazinamide—XDH—Metabolism—APIP—chronic obstructive pulmonary disease	0.000227	0.00454	CbGpPWpGaD
Pyrazinamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00278	CcSEcCtD
Pyrazinamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00278	CcSEcCtD
Pyrazinamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00274	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.0027	CcSEcCtD
Pyrazinamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00254	CcSEcCtD
Pyrazinamide—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000194	0.00388	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000194	0.00387	CbGpPWpGaD
Pyrazinamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00243	CcSEcCtD
Pyrazinamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00234	CcSEcCtD
Pyrazinamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00231	CcSEcCtD
Pyrazinamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00231	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00231	CcSEcCtD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00362	CbGpPWpGaD
Pyrazinamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00219	CcSEcCtD
Pyrazinamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00218	CcSEcCtD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00341	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00341	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00341	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000168	0.00336	CbGpPWpGaD
Pyrazinamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00211	CcSEcCtD
Pyrazinamide—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000166	0.00332	CbGpPWpGaD
Pyrazinamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000166	0.0021	CcSEcCtD
Pyrazinamide—AOX1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000162	0.00323	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00319	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GC—chronic obstructive pulmonary disease	0.000158	0.00314	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000157	0.00312	CbGpPWpGaD
Pyrazinamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00196	CcSEcCtD
Pyrazinamide—XDH—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000151	0.003	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00015	0.00299	CbGpPWpGaD
Pyrazinamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00188	CcSEcCtD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00292	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000147	0.00292	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GC—chronic obstructive pulmonary disease	0.000147	0.00292	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00275	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00272	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000136	0.00272	CbGpPWpGaD
Pyrazinamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00169	CcSEcCtD
Pyrazinamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00168	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00168	CcSEcCtD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00263	CbGpPWpGaD
Pyrazinamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00158	CcSEcCtD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.00237	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00233	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00223	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00214	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.0021	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.85e-05	0.00196	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.73e-05	0.00194	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	9.45e-05	0.00188	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HDAC2—chronic obstructive pulmonary disease	8.64e-05	0.00172	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.64e-05	0.00172	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.61e-05	0.00172	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.51e-05	0.0017	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KL—chronic obstructive pulmonary disease	8.03e-05	0.0016	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.01e-05	0.0016	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8e-05	0.0016	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GCLC—chronic obstructive pulmonary disease	7.91e-05	0.00158	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.77e-05	0.00155	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.6e-05	0.00152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.51e-05	0.0015	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7.34e-05	0.00146	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CTGF—chronic obstructive pulmonary disease	7.22e-05	0.00144	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.2e-05	0.00144	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.2e-05	0.00144	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.16e-05	0.00143	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.92e-05	0.00138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.86e-05	0.00137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.86e-05	0.00137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.83e-05	0.00136	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.73e-05	0.00134	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.65e-05	0.00133	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.32e-05	0.00126	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.27e-05	0.00125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.23e-05	0.00124	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.00123	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	6.02e-05	0.0012	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.97e-05	0.00119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.00119	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.89e-05	0.00117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.00117	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.55e-05	0.00111	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.49e-05	0.00109	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.47e-05	0.00109	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.27e-05	0.00105	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.00104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.2e-05	0.00104	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.1e-05	0.00102	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	5.02e-05	0.001	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.84e-05	0.000965	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.83e-05	0.000964	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.78e-05	0.000954	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.77e-05	0.000952	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.59e-05	0.000915	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.53e-05	0.000903	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	4.23e-05	0.000843	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	4.04e-05	0.000805	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.69e-05	0.000736	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000705	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.41e-05	0.00068	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-05	0.000674	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000655	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.17e-05	0.000632	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—chronic obstructive pulmonary disease	3.14e-05	0.000627	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.08e-05	0.000615	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.87e-05	0.000571	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	2.67e-05	0.000532	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	2.62e-05	0.000522	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.45e-05	0.000488	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.38e-05	0.000474	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.000455	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.21e-05	0.000441	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—chronic obstructive pulmonary disease	2.01e-05	0.000401	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.000336	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000332	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.55e-05	0.00031	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000303	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000259	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.28e-05	0.000256	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000234	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000233	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.00023	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000215	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000203	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.01e-06	0.00018	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.88e-06	0.000177	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.28e-06	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.85e-06	0.000157	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.91e-06	0.000138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.61e-06	0.000132	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.33e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.1e-06	0.000102	CbGpPWpGaD
